Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - GENETHERA INC | exhibit321_ex32z1.htm |
| EX-31.1 - EXHIBIT 31.1 - GENETHERA INC | exhibit311_ex31z1.htm |
| EX-31.2 - EXHIBIT 31.2 - GENETHERA INC | exhibit312_ex31z2.htm |
| 10-K - FORM 10K - GENETHERA INC | f10k2015revbtli51116_10k.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of GeneThera, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2015, as filed with the Securities and Exchange Commission (the “Report”), I, Tannya L. Irizarry, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
May13, 2016 /s/ Tannya L Irizarry
Tannya L Irizarry
Chief Financial Officer (Interim)
(Principal Financial/Accounting Officer)